OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Peapod Lane Capital LLC

Peapod Lane Capital LLC lifted its stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 19.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 571,110 shares of the medical instruments supplier's stock after purchasing an additional 91,787 shares during the quarter. OraSure Technologies comprises 2.2% of Peapod Lane Capital LLC's portfolio, making the stock its 19th largest position. Peapod Lane Capital LLC owned approximately 0.74% of OraSure Technologies worth $1,925,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its position in OraSure Technologies by 5.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 76,932 shares of the medical instruments supplier's stock worth $278,000 after buying an additional 3,828 shares during the period. Invesco Ltd. grew its position in shares of OraSure Technologies by 3.4% during the fourth quarter. Invesco Ltd. now owns 127,526 shares of the medical instruments supplier's stock worth $460,000 after acquiring an additional 4,240 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of OraSure Technologies by 202.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 5,234 shares during the period. Legal & General Group Plc lifted its position in OraSure Technologies by 32.3% in the 4th quarter. Legal & General Group Plc now owns 23,626 shares of the medical instruments supplier's stock valued at $85,000 after purchasing an additional 5,770 shares during the last quarter. Finally, Orion Portfolio Solutions LLC boosted its stake in OraSure Technologies by 10.7% during the 4th quarter. Orion Portfolio Solutions LLC now owns 61,170 shares of the medical instruments supplier's stock valued at $221,000 after purchasing an additional 5,929 shares during the period. Institutional investors own 93.50% of the company's stock.

OraSure Technologies Price Performance

Shares of NASDAQ OSUR traded up $0.05 during midday trading on Friday, reaching $3.10. 682,037 shares of the company traded hands, compared to its average volume of 745,489. The company has a market cap of $231.88 million, a price-to-earnings ratio of -7.38 and a beta of 0.45. The stock has a 50-day moving average price of $2.84 and a 200 day moving average price of $3.27. OraSure Technologies, Inc. has a 52 week low of $2.36 and a 52 week high of $4.92.

OraSure Technologies announced that its board has approved a share buyback program on Monday, March 24th that permits the company to repurchase $40.00 million in outstanding shares. This repurchase authorization permits the medical instruments supplier to reacquire up to 15.6% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board believes its shares are undervalued.

Analysts Set New Price Targets

Several equities research analysts have commented on OSUR shares. Wall Street Zen upgraded shares of OraSure Technologies from a "sell" rating to a "hold" rating in a research note on Saturday, May 17th. Evercore ISI reissued an "in-line" rating and issued a $3.00 price objective on shares of OraSure Technologies in a report on Monday, May 19th.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.